Latest News for: ccne1

Edit

AACR 2026 – Selective targeting of CCNE1 using molecular glue degraders for the treatment of CCNE1 amplified cancers (Monte Rosa Therapeutics Inc)

Public Technologies 22 Apr 2026
‌Selective targeting of CCNE1 using molecular glue degraders for the treatment of CCNE1 amplified cancers ... ‌CCNE1 (Cyclin E1) is a Target for Solid Tumors with Deregulated Cyclin E1 ... First-in-class Cyclin E1 degraders for CCNE1 ... CCNE1 ... CCNE1.K118 ... CCNE1.
  • 1
×